Are statins a treatment option for COPD?

Murray C. Alternative vision of the future: projecting mortality and disability. In: Murray C, Lopez A, eds. The global burden of disease . Boston , MA: Harvard University Press, 1966;361-375.

Google Scholar

Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006;27:627-643.

Google Scholar

Bakakos P, Kostikas Κ, Loukidis S. COPD and comorbidities. Pneumon 2010;23:24-27.

Google Scholar

Barnes PJ, Celli BR. Systemic manifestation and comorbities in COPD. Eur Resp J 2009; 33: 1165-1185.

Google Scholar

Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analyse. Thorax 2004; 59: 574-580.

Google Scholar

Oudijk EJ, Lammmers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Resp J 2003; 46 (suppl):5s-13s.

Google Scholar

Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstruc-tive pulmonary disease. Circulation 2003;107:1514–19.

Google Scholar

Surinder Janda, Kirly Park, Mark Fitz Gerarld, Mahyar Etminan, Jonh Swiston. Statin in COPD Asystematic review. Chest 2009; 136:734-743.

Google Scholar

Young RP, Hopkins R, Eaton TE. Pharmacological action of statin: potential utility in COPD. Eur Resp Rev 2009, 18:114. 222-232).

Google Scholar

10.

Bartziokas K, Papaioannou A, Minas M, et al. Pulm Pharmacol Ther 2011; 24:625-631.

Google Scholar

11.

Keddisi JI, Younis WG, Chbier EA, et al. The use of statin iand lung function in current and former smokers. Chest 2007, 132: 1764-1771.

Google Scholar

12.

Takahashi S, Nakamura H, Seki M, et al. Reversal of elastase induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice. Am J Physiol Lung Cell Mol Physiol 2008; 294:L882-L890.

Google Scholar

13.

Kiener PA, Davis PM, Murray JL, et al. Stimulation of inflammatory responses in vitro by lipophilic HMG-CoA reductase inhibitors. Int Immunopharmacol 2001, I:105-118.

Google Scholar

Submit your paper

Instructions to Authors

Issues

Send by email

Improving the process of care in chronic obstructive pulmonary disease: The COPD Assessment Test (CAT) in the armature of the tools assessing COPD

Sarcopenia in COPD patients: Prevalence, patients’ characteristics and predictive factors

Indexes

Keywords index

Topics index

Authors index

eISSN:	1791-4914
ISSN:	1105-848X